{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:36:02Z","timestamp":1787164562026,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>The diagnostic algorithm and nomenclature of pituitary neuroendocrine tumors have evolved over the past decade, beginning with simpler categorical schemes focused on histomorphologic features and moving to a more sophisticated lineage-specific categorization. This contemporary overview highlights a multimodal approach to pituitary neuroendocrine tumors with a focus on changes in nomenclature, classification, and subclassification; including, brief comments on treatment, and new guidelines for genetic screening, particularly for young patients with such neoplasms.<\/jats:p>","DOI":"10.1097\/pap.0000000000000367","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T11:57:21Z","timestamp":1662551841000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["An Overview of Pituitary Neuroendocrine Tumors (PitNET) and Algorithmic Approach to Diagnosis"],"prefix":"10.1097","volume":"30","author":[{"given":"Maria A.","family":"Gubbiotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubair","family":"Baloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","article-title":"Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification","volume":"34","author":"Asa","year":"2021","journal-title":"Mod Pathol"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","article-title":"Biomarkers of aggressive pituitary adenomas","volume":"49","author":"Mete","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.21037\/tcr-20-3446","article-title":"Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Cancer Res"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.semdp.2013.06.002","article-title":"Therapeutic implications of accurate classification of pituitary adenomas","volume":"30","author":"Mete","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"R9-20250615","first-page":"1275","article-title":"Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas","volume":"77","author":"Asa","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20250615","first-page":"2165","article-title":"The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph","volume":"81","author":"Asa","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","article-title":"A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins","volume":"104","author":"Lamolet","year":"2001","journal-title":"Cell"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1126\/science.1062736","article-title":"Pituitary development: regulatory codes in mammalian organogenesis","volume":"295","author":"Scully","year":"2002","journal-title":"Science"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/ERC-11-0135","article-title":"PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis","volume":"19","author":"Palmieri","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0025-6196(11)63002-4","article-title":"Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases","volume":"71","author":"Young","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1227\/NEU.0000000000001188","article-title":"Functional gonadotroph adenomas: case series and report of literature","volume":"79","author":"Cote","year":"2016","journal-title":"Neurosurgery"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02914485","article-title":"Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: An immunocytochemical and ultrastructural anafysis of 300 cases","volume":"4","author":"Kontogeorgos","year":"1993","journal-title":"Endocr Pathol"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12022-020-09615-4","article-title":"Utility of GATA-3 expression in the analysis of Pituitary Neuroendocrine Tumour (PitNET) transcription factors","volume":"31","author":"Turchini","year":"2020","journal-title":"Endocr Pathol"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","article-title":"GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors","volume":"32","author":"Mete","year":"2019","journal-title":"Mod Pathol"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R20-20250615","first-page":"617","article-title":"Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study","volume":"98","author":"Horvath","year":"1980","journal-title":"Am J Pathol"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2004.04.016","article-title":"Silent corticotroph adenomas: further clinical and pathological observations","volume":"35","author":"Lopez","year":"2004","journal-title":"Hum Pathol"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","article-title":"Clinical features of silent corticotroph adenomas","volume":"154","author":"Alahmadi","year":"2012","journal-title":"Acta Neurochir"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","article-title":"Cytokeratin profiles in pituitary neuroendocrine tumors","volume":"107","author":"Asa","year":"2021","journal-title":"Hum Pathol"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00234-002-0774-2","article-title":"Gender-related differences in prolactin secretion in pituitary prolactinomas","volume":"44","author":"Nishioka","year":"2002","journal-title":"Neuroradiology"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cncr.10676","article-title":"Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas","volume":"95","author":"Ma","year":"2002","journal-title":"Cancer"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/jcm8111962","article-title":"The Clinicopathological Spectrum of Acromegaly","volume":"8","author":"Akirov","year":"2019","journal-title":"J Clin Med"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form","volume":"19","author":"Obari","year":"2008","journal-title":"Endocr Pathol"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12020-019-02029-1","article-title":"Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up","volume":"66","author":"Lv","year":"2019","journal-title":"Endocrine"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/jcm10112254","article-title":"An update on pituitary neuroendocrine tumors leading to acromegaly and gigantism","volume":"10","author":"Asa","year":"2021","journal-title":"J Clin Med"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jcem-42-5-857","article-title":"Human mixed somatotrophic and lactotrophic pituitary adenomas","volume":"42","author":"Corenblum","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2008.03514.x","article-title":"Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience","volume":"71","author":"Erickson","year":"2009","journal-title":"Clin Endocrinol"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","article-title":"Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases","volume":"47","author":"Horvath","year":"1981","journal-title":"Cancer"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12022-018-9562-3","article-title":"Plurihormonal pituitary tumor of Pit-1 and SF-1 lineages, with synchronous collision corticotroph tumor: a possible stem cell phenomenon","volume":"30","author":"Tordjman","year":"2019","journal-title":"Endocr Pathol"},{"key":"R36-20250615","first-page":"842","article-title":"H-ras mutations in human pituitary carcinoma metastases","volume":"78","author":"Pei","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3835(98)00013-5","article-title":"Loss of Rb expression in an ACTH-secreting pituitary carcinoma","volume":"126","author":"Hinton","year":"1998","journal-title":"Cancer Lett"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2265.1994.tb02797.x","article-title":"p53 gene mutations in pituitary adenomas: rare events","volume":"41","author":"Levy","year":"1994","journal-title":"Clin Endocrinol"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12022-007-9006-y","article-title":"P53 gene mutations in pituitary carcinomas","volume":"18","author":"Tanizaki","year":"2007","journal-title":"Endocr Pathol"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","article-title":"Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX Mutations","volume":"106","author":"Casar-Borota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fonc.2018.00510","article-title":"Identification of novel genes involved in the pathogenesis of an acth-secreting pituitary carcinoma: A case report and literature review","volume":"8","author":"Guo","year":"2018","journal-title":"Front Oncol"},{"key":"R42-20250615","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1385\/ENDO:20:3:265","article-title":"Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs","volume":"20","author":"Shimon","year":"2003","journal-title":"Endocrine"},{"key":"R43-20250615","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau","year":"1973","journal-title":"Science"},{"key":"R44-20250615","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1210\/endo-95-4-968","article-title":"Effects of somatostatin on the secretion by thyrotropin and prolactin","volume":"95","author":"Vale","year":"1974","journal-title":"Endocrinology"},{"key":"R45-20250615","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem-38-5-742","article-title":"Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor","volume":"38","author":"Siler","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20250615","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/endo-108-1-281","article-title":"Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture","volume":"108","author":"Richardson","year":"1981","journal-title":"Endocrinology"},{"key":"R47-20250615","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1\u2013sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R48-20250615","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"R49-20250615","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mce.2007.11.024","article-title":"Somatostatin agonist for treatment of acromegaly","volume":"286","author":"Ben-Shlomo","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R50-20250615","doi-asserted-by":"crossref","first-page":"e36411","DOI":"10.1371\/journal.pone.0036411","article-title":"Meta-analysis on the effects of octreotide on tumor mass in acromegaly","volume":"7","author":"Giustina","year":"2012","journal-title":"PLoS One"},{"key":"R51-20250615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/JME-08-0110","article-title":"Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro","volume":"42","author":"de Bruin","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"R53-20250615","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:02Z","timestamp":1750003382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000367","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}